rewirebio.iobenchmarks
Configuration

Combined

Combined as evaluated in the cited study. Paper-specific evaluated pipeline; exact checkpoint not inferred from label

SourcesEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Val Accuracy; XML row4 column2

1 evaluation · 7 results

Overview

Key specifications have not been extracted for this record. See the linked evaluation and sources for the reported setup.

limited source coverage · Automated source review, 2026-09-17. All specifications and missing details

Model Capabilities & Hardware Requirements

Deployment facts recorded for Combined. Fields the record does not carry are marked not recorded.

ParametersNot recorded
Minimum VRAMNot recorded
Inference LatencyNot recorded
Context WindowNot recorded
AccessNot recorded
LicenseNot recorded

Evaluated Checkpoint: Paper-specific evaluated pipeline; exact checkpoint not inferred from label

Evaluations and results

1 evaluation · 7 results. Different protocols are not a single leaderboard.

Protocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction) · Dataset: Protective-antigen classification feature comparison

Sorted by Accuracy (validation split) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationAccuracy (validation split)AUPRCAUROCMCCRecallSpecificityWeighted F1
CombinedEvaluation0.97 ± 0.0040.92 ± 0.0130.970.85 ± 0.0210.83 ± 0.0450.99 ± 0.0040.97 ± 0.004
All 7 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: CombinedProtocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction)
Dataset: Protective-antigen classification feature comparison
0.85 ± 0.021 MCC
unitless · higher

Uncertainty: ± 0.021 (type not stated)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined: Protective-antigen classification feature comparison

Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.

Aggregation: Not reported

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column MCC; XML row4 column6
Configuration: CombinedProtocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction)
Dataset: Protective-antigen classification feature comparison
0.99 ± 0.004 Specificity
fraction · higher

Uncertainty: ± 0.004 (type not stated)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined: Protective-antigen classification feature comparison

Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.

Aggregation: Not reported

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Specificity; XML row4 column4
Configuration: CombinedProtocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction)
Dataset: Protective-antigen classification feature comparison
0.97 ± 0.004 Weighted F1
fraction · higher

Uncertainty: ± 0.004 (type not stated)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined: Protective-antigen classification feature comparison

Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.

Aggregation: Not reported

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Weighted F1; XML row4 column5
Configuration: CombinedProtocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction)
Dataset: Protective-antigen classification feature comparison
0.97 ± 0.004 Accuracy (validation split)
fraction · higher

Uncertainty: ± 0.004 (type not stated)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined: Protective-antigen classification feature comparison

Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.

Aggregation: Not reported

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Val Accuracy; XML row4 column2
Configuration: CombinedProtocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction)
Dataset: Protective-antigen classification feature comparison
0.92 ± 0.013 AUPRC
fraction · higher

Uncertainty: ± 0.013 (type not stated)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined: Protective-antigen classification feature comparison

Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.

Aggregation: Not reported

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column AUPRC; XML row4 column7
Configuration: CombinedProtocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction)
Dataset: Protective-antigen classification feature comparison
0.83 ± 0.045 Recall
fraction · higher

Uncertainty: ± 0.045 (type not stated)

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined: Protective-antigen classification feature comparison

Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.

Aggregation: Not reported

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Sensitivity; XML row4 column3
Configuration: CombinedProtocol: Protective-antigen classification feature comparison (vaccine-antigen candidate prediction)
Dataset: Protective-antigen classification feature comparison
0.97 AUROC
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Combined: Protective-antigen classification feature comparison

Original 509 features vs ESM 1,280 features vs combined 1,789 features. 372 protection-positive and 3,720 protection-negative samples.

Aggregation: Not reported

Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column AUROC; XML row4 column8

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Use this configuration

How it works, versions and access

How it works

Evaluation in this paper

Paper-specific evaluated pipeline; exact checkpoint not inferred from label

SourcesEnhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features · Table 1., row Combined, column Val Accuracy; XML row4 column2
Strengths, limitations and unresolved questions

Strengths and limitations

Strengths and considerations

No source-reviewed explanatory claims are recorded here yet.

Limitations and conditions

No source-reviewed explanatory claims are recorded here yet.

Profile review details

Primary-source transcription and separate automated review. No human sign-off or experimental reproduction.

Stable record: paper-model-f2cef2e59da25c476f

Specifications

Inputs, training, access and other details

Explanatory profile: limited source coverage · Automated source review, 2026-09-17. Review applies to the cited claims; unresolved fields are listed below. Numerical results retain their own review status.

Inputs, outputs and configuration
PropertyDescription and evidence
Model typeNot extracted or verified for this record.
InputsNot extracted or verified for this record.
OutputsNot extracted or verified for this record.
ParametersNot extracted or verified for this record.
Known versionsNot extracted or verified for this record.
Training dataNot extracted or verified for this record.
Context limitsNot extracted or verified for this record.
AccessNot extracted or verified for this record.
Code licenceNot extracted or verified for this record.
Weights licenceNot extracted or verified for this record.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

2 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Evaluation in this paper
Paper-specific evaluated pipeline; exact checkpoint not inferred from label
Individual claims
Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features

Original source ↗

Table 1., row Combined, column Val Accuracy; XML row4 column2

Version: preprint version in PMC
Retrieved: 2026-09-17T07:56:15.123850+00:00

source checked

automated source review · 2026-09-17

Audit details

Primary-source transcription and separate automated review. No human sign-off or experimental reproduction.

Field: attributes.profile.sections.0.body

Source artifact SHA-256: b76fff917addd0e9ff8a2fc843496132ecf832d3ceef248e3edf2dbc78baab5f

Hash scope: Exact retrieved primary paper artifact bytes.

Inspected artifact

Introduction
Combined as evaluated in the cited study. Paper-specific evaluated pipeline; exact checkpoint not inferred from label
Individual claims
Enhancing Vaxign-DL for Vaccine Candidate Prediction with added ESM-Generated Features

Original source ↗

Table 1., row Combined, column Val Accuracy; XML row4 column2

Version: preprint version in PMC
Retrieved: 2026-09-17T07:56:15.123850+00:00

source checked

automated source review · 2026-09-17

Audit details

Primary-source transcription and separate automated review. No human sign-off or experimental reproduction.

Field: attributes.profile.summary

Source artifact SHA-256: b76fff917addd0e9ff8a2fc843496132ecf832d3ceef248e3edf2dbc78baab5f

Hash scope: Exact retrieved primary paper artifact bytes.

Inspected artifact

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: needs review

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID paper-model-f2cef2e59da25c476f.

Related records

How to cite

Combined. Rewire biological model benchmark database, release 2026-11-21-c8bea25e5abb. https://benchmarks.rewirebio.io/database/configuration/paper-model-f2cef2e59da25c476f/

Release 2026-11-21-c8bea25e5abb. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.

The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence

Suggest a correction